This symposium unites multidisciplinary experts from Memorial Sloan Kettering Cancer Center and around the world, spanning specialties such as hematology, nephrology, surgery, pathology, immunology, and bioethics. The organizers will explore critical topics pertaining to the evaluation and management of plasma cell dyscrasia patients being considered for kidney transplantation